Data-driven immunology research is evolving quickly and involves complex, high-throughput data sets. At the interface between immunology and virology, or immunology and cancer with immunotherapies revolutionizing patient care, recent developments are numerous. In this context, we thought it was very
Read more
Towards a personalized radiation therapy cancer treatment NovaGray is developing a new generation of companion diagnostic tests aimed at improving radiation therapy planning. The overarching goal of NovaGray lies in the practitioner’s ability to tailor the dose and the sessions’
Read more
After a hearing before an international jury on February 21st, the project “Montpellier University of Excellence” (MUSE) was awarded the label “Initiatives – Science – Innovation – Territoires – Economie” (I-SITE) established within the French program “Investissements d’Avenir”. The project involves
Read more
The 7th Meeting on Nuclear Receptors will be held from Thursday May 18th to Friday May 19th in Montpellier in the Amphitheater of the former Faculty of Medicine. This scientific meeting will make it possible to strengthen the links previously
Read more
The next ASCO GI will be held from 19 january to 21 january at San Franscisco more information
Thursday 19 January September, 02:00 pm : « ETargeting Breast Cancer stem cells » Emmanuelle Charafe-Jauffret/Christophe Ginestier, CRCM/Institut Paoli Calmettes, Marseille Contact : Julie.Pannequin@igf.cnrs.fr
Heinz-Josef Lenz, MD, of the University of Southern California, and Marc Ychou, MD, of the Centre Régional de Lutte Contre Le Cancer, discuss study findings on FOLFIRINOX combined with targeted therapy according to RAS status for colorectal cancer patients with initially
Read more
The Labex EpiGenMed is glad to announce you the launch of our post-doc campaign 2015 that offers 10 fellowships for a period of 2 years (1 year renewable). Interested candidates should now apply among the teams whose projects have been selected this year. You will find all the information on the website: www.epigenmed.fr
Call for Application – New Group Leader in Cancer Biology More information
The microRNA personalized medicine project in rectal cancer “miCRA“ to receive financial support from the French Public Investment Bank Croissy-Beaubourg and Montpellier, March 24 2014 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro
Read more
English
Français